{"@context":{"@vocab":"https://schema.org/"},"@type":"Legislation","@id":"https://api.ai-analytics.org/trade-case/8897#inv","name":"Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same; Inv. No. 337-TA-3890 (Violation)","legislationIdentifier":"337-3890","description":"USITC Section 337 (unfair imports / IP) investigation 337-3890 — Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same. Concluded 2026-06-17.","url":"https://ids.usitc.gov/case/8355/investigation/8897","isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","investigation":{"investigation_id":8897,"investigation_number":"337-3890","case_class":"SECTION_337","type":"Unfair Imports","title":"Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same; Inv. No. 337-TA-3890 (Violation)","product":"Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same","phase":"Violation 1","start_date":null,"end_date":"2026-06-17","active":false,"ids_url":"https://ids.usitc.gov/case/8355/investigation/8897","url":"https://api.ai-analytics.org/trade-case/8897"},"_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://ids.usitc.gov/","primary_source_dataset":"USITC Investigations Database System (IDS)","generated_at":"2026-06-26T22:44:41.481Z"}}